Drug interaction software and the risk of using ceftriaxone with therapeutic hemapheresis

In July 2007, the U.S. Food and Drug Administration (FDA) issued a MedWatch alert regarding a potentially deadly drug interaction between ceftriaxone and calcium or calcium-containing products.[1][1] The warning, which advised against administration of these products within 48 hours of each other,